Stock Chart
BIOA
Type: SELL wallstreet
Strike: $10
Premium: $1.40
Expiry: Apr 17, 2026
Target: $10
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About BIOA - BioAge Labs, Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
Key Statistics
More BIOA Analysis
This BIOA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BIOA's price movements with trendlines, gamma walls, and key support/resistance levels.